Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Nussenzweig: Discovery & Characterization of bNAbs |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2013-12-20 |
| Study Made Public: | 2015-08-28 |
Title
Neutralization and Binding Data for 4 Germline Versions of bNAbs from HIV-Infected Patients
Description
CAVD 435 is an immunogenicity study of broadly neutralizing antibodies to investigate the development of four germline versions of broadly neutralizing antibodies (bNAbs) that were previously identified in HIV-infected patients.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.